Among the many topics covered in the comprehensive Q121 Soft Tissue Fixation Market Recap* are:

It's time to get out there again and re-connect, and SmartTRAK is excited to be attending ISASS21, the International Society for the Advancement of Spine Surgery's 21st annual conference, at the Loews Miami Beach Hotel in South Beach Miami, May 13-15.

SmartTRAK will be represented by Julianne Burns, General Manager, Spine. Please contact us if you would like a meeting.

Click to read some recent SmartTRAKanalysis articles by Julianne that were featured on the blog:

• Top Trends in Spine in 2021: A Market in Motion
• Spine's Next Big Biomaterial: DiFusion Technologies’ ZFUZE

We are excited to announce the addition of the full market view of Orthopedic Pediatrics (US) to the SmartTRAK platform, featuring 3 modules covering Pediatric Trauma, Pediatric Extremities and Pediatric Spine!

Coverage includes:

• Pediatric Trauma:
  • Pelvis
  • Femur
  • Proximal Tibia
    Technologies covered include Guided Growth Plates, Anatomic Plates, IM Nails (including Elastic Nails), Deformity Correction and more!

• Pediatric Extremities
  
  • Upper Extremities Fixation
  • Foot and Ankle Fixation
    Technologies featured include Cannulated Screws, Clavicle Plates, Wrist Fusion Plates, External Fixation and more!

• Pediatric Spine:
  • Adolescent idiopathic Scoliosis
  • Early Onset Scoliosis
  • Neuromuscular Scoliosis
    Technologies included feature Growing Rods, Fusion Technologies, Vertebral Body Tethering, ApiFix and more!

SmartTRAK outlines consequences COVID-19 is expected to have on the European Trauma & Extremities Market

Twenty-five years of orthopedic business planning has taught me to monitor certain non-business factors when setting goals. Trends in weather patterns, age demographics, lifestyle and activities can have a direct influence on market growth. In 2020, the COVID-19 pandemic negatively impacted the European market with the shutdown of various countries and the ensuing changes in lifestyle such as reduced travel, work and sporting activities. In 2020, SmartTRAK predicted the European Trauma market fell by around 25% with extremities at nearly -50% in the midst of COVID-19 lockdowns. Similar market pressures are also expected during 2021.

Despite market challenges due to the COVID-19 pandemic, 2020 was a game-changing year for enabling technology for orthopedic surgery with robotics hitting an inflection point in acceptance, with record placements in Q420, and enabling technology across the entire continuum of care making significant inroads.

In Q420, MAKO* robot demand drove much of the 12.3% growth in Stryker’s* US Ortho Other segment. In 2020, MAKO’s installed base grew by 33%, and in Q420 hit a milestone of > 100 system installations at major teaching institutions, ASCs and in competitive accounts in the quarter. In fact, according to the Company, MAKO is now available in ~50% of fellowship programs at teaching institutions in US, as well as some in Europe, which will help the transition to standard of care. Stryker noted that new market entrants (Zimmer Biomet’s* ROSA*, Smith & Nephew’s* CORI* and DePuy Synthes’* VELYS*) have not slowed MAKO momentum.

Among the many topics covered in the comprehensive Q420/FY20 CAS Ortho Market Recap* are:

COVID-19 threw a curveball to spine and orthopedic implant companies in 2020 with the downturn in elective procedures, but one area that continued to make inroads was enabling technologies. Given increasing advances and expanding adoption of these technologies, even during uncertain times, SmartTRAK highlights some significant trends to watch in 2021, including:

1. Flexible Business Models
Companies with robots (Stryker*, MAKO*, Zimmer Biomet*, ROSA*, Smith & Nephew*, NAVIO*/CORI*, Medtronic*, Mazor X*, Globus*, Excelsius GPS) continued to grow at above-market growth in 2020. Record-breaking robotic and navigation system placements in Q3 and Q420 bode well for ...

Healthy growth closes out Q420 as the trauma segment recovers in the second half of the year hitting pre-COVID levels.

Despite the rise in COVID cases during Q4, the Trauma Market fared well resulting in positive YoY revenue gains that represented healthy, pre-COVID level volumes. Trauma players cited another quarter of healthy trauma growth, as the second half of the year ended on an upswing (+5.6% vs. H219). Top US market leaders, DePuy Synthes (49.4% Q420 US share), Stryker (27.3%) and Smith & Nephew (9.8%) all reported improved sequential gains.

Among the many topics covered in the comprehensive Q420/FY20 Trauma Market Recap* are:

Surge in COVID-19 Wipes Out Some Procedural Recovery

The surge of COVID-19 cases in Q420 likely brought on by holiday gatherings threatened to wash away the beginning of elective procedure recovery in Q3. In some regions of the US, healthcare facilities once again found themselves underwater as they struggled to care for COVID patients. OUS, Britain and other countries continued to face shutdowns and delay of non-urgent procedures.

Among the many topics covered in the comprehensive Q420/FY20 Total Joints Market Recap* are:

Facing the prevailing headwinds of the pandemic, the MedTech industry presses on with product innovation and plans for the future. SmartTRAK reports daily on the challenges still ahead, covering all aspects of the Orthopedic market: Extremities, OrthoBio, Spine, Computer Assisted Surgery, Total Joints, Trauma, Soft Tissue Fixation and EU Extremities and Trauma.

The following is just a small sampling of the Orthopedic updates from around the world compiled, reviewed and posted in real time last week by our SmartTRAK analysts. We constantly monitor the worldwide MedTech industry, sifting through the noise to present to our subscribers the most relevant international news, trends, new products, patents, financial data and competitor developments in the global Life Sciences industry.